1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Cancer, Multiple Indications: new trials by email Literature Review of Cancer, Multiple Indications trials Research Report on Cancer, Multiple Indications
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Ascending Dose (MDX1105-01) Anti-PDL-1 antibody - Cancer, Multiple Indications | Phase 1 | Completed | Bristol-Myers Squibb | 281 | 2009-02-01 | 2015-09-07 |
Neoplasms (1)
BMS-936559 (1)
United States (1)